Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Whitehawk Therapeutics (WHWK) Preferred Shares: 2020

  • Whitehawk Therapeutics' Preferred Shares was N/A to $1,000 in Q4 2020 from the same period last year, while for Dec 2020 it was $1,000, marking a year-over-year change of. This contributed to the annual value of $1,000 for FY2020, which is N/A change from last year.
  • Latest data reveals that Whitehawk Therapeutics reported Preferred Shares of $1,000 as of Q4 2020.
  • Whitehawk Therapeutics' Preferred Shares' 5-year high stood at $1,000 during Q4 2020, with a 5-year trough of $1,000 in Q4 2020.
  • Moreover, its 1-year median value for Preferred Shares was $1,000 (2020), whereas its average is $1,000.